Transcriptomics,Genomics

Dataset Information

27

Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin


ABSTRACT: Advanced ovarian cancers are initially responsive to chemotherapy with platinum drugs but develop drug resistance in most cases. We showed recently that hepatocyte growth factor (HGF) enhances death of human ovarian cancer cell lines treated with cisplatin (CDDP) and that this effect is mediated by the p38 mitogen-activated protein kinase. In this work, we integrated genome-wide expression profiling, in silico data survey, and functional assays to identify transcripts regulated in SK-OV-3 ovarian cancer cells made more responsive to CDDP by HGF. Using oligonucleotide microarrays, we found that HGF pretreatment changes the transcriptional response to CDDP. Quantitative reverse transcription-PCR not only validated all the 15 most differentially expressed genes but also confirmed that they were primarily modulated by the combined treatment with HGF and CDDP and reversed by suppressing p38 mitogen-activated protein kinase activity. Among the differentially expressed genes, we focused functional analysis on two regulatory subunits of the protein phosphatase 2A, which were down-modulated by HGF plus CDDP. Decrease of each subunit by RNA interference made ovarian cancer cells more responsive to CDDP, mimicking the effect of HGF. In conclusion, we show that HGF and CDDP modulate transcription in ovarian cancer cells and that this transcriptional response is involved in apoptosis regulation. We also provide the proof-of-concept that the identified genes might be targeted to either increase the efficacy of chemotherapeutics or revert chemotherapy resistance. Overall design: Two of the time-course experiments, done independently (TR5 and TR7), were analyzed. time 0 (h0) time 6 hours (h6) time 12 hours (h12) time 24 hours (h24) with (hgf1) and without addition of HGF (hgf0)

INSTRUMENT(S): [HG-U133A] Affymetrix Human Genome U133A Array

SUBMITTER: Raffaele A Calogero  

PROVIDER: GSE16424 | GEO | 2009-06-10

SECONDARY ACCESSION(S): PRJNA116369

REPOSITORIES: GEO

altmetric image

Publications

Genes regulated by hepatocyte growth factor as targets to sensitize ovarian cancer cells to cisplatin.

Olivero Martina M   Ruggiero Tina T   Saviozzi Silvia S   Rasola Andrea A   Coltella Nadia N   Crispi Stefania S   Di Cunto Ferdinando F   Calogero Raffaele R   Di Renzo Maria Flavia MF  

Molecular cancer therapeutics 20060501 5


Advanced ovarian cancers are initially responsive to chemotherapy with platinum drugs but develop drug resistance in most cases. We showed recently that hepatocyte growth factor (HGF) enhances death of human ovarian cancer cell lines treated with cisplatin (CDDP) and that this effect is mediated by the p38 mitogen-activated protein kinase. In this work, we integrated genome-wide expression profiling, in silico data survey, and functional assays to identify transcripts regulated in SK-OV-3 ovaria  ...[more]

Similar Datasets

| GSE24589 | GEO
2013-12-31 | E-GEOD-24589 | ArrayExpress
2013-12-31 | E-GEOD-38551 | ArrayExpress
2013-12-31 | E-GEOD-38545 | ArrayExpress
| PRJNA133587 | ENA
| GSE108139 | GEO
2011-05-24 | E-GEOD-29450 | ArrayExpress
2012-07-31 | E-GEOD-39345 | ArrayExpress
2012-01-01 | GSE26704 | GEO
2012-01-01 | E-GEOD-26704 | ArrayExpress